Suzgo B Zimba

Dados Biográficos

ID7766686
NOMESuzgo B Zimba
PRENOMESSuzgo B
SOBRENOMEZimba
ASSINATURAZIMBA S B
AFILIAÇÕESElizabeth Glaser Pediatric AIDS Foundation
VERIFICADONão
TOTAL DE OBRAS5
TOTAL DE CITAÇÕES0
TOTAL COMO AUTOR5
TOTAL COMO EDITOR0
PRIMEIRO ANO DE PUBLICAÇÃO2020
ANO MAIS RECENTE DE PUBLICAÇÃO2024
ÍNDICE H0

  • Enhancing Sars-CoV-2 surveillance in Malawi using telephone syndromic surveillance from July 2020 to April 2022

    Open AccessGodfrey Woelk, Thulani Maphosa et al.ARTICLEBMJ Global Health2024

    INTRODUCTION: Monitoring the SARS-CoV-2 pandemic in low-resource countries such as Malawi requires cost-effective surveillance strategies. This study explored the potential utility of phone-based syndromic surveillance in terms of its reach, monitoring trends in reported SARS-CoV-2-like/influenza-like symptoms (CLS/ILS), SARS-CoV-2 testing and mortality. METHODS: Mobile phone-based interviews were conducted between 1 July 2020 and 30 April 2022, …

  • Factors associated with Covid-19 vaccine receipt among mobile phone users in Malawi

    Open AccessLucky Makonokaya, Lester Kapanda et al.ARTICLEPLOS Global Public Health2024

    Malawi recommended COVID-19 vaccines for adults aged ≥18 years in March 2021. We assessed factors associated with receiving COVID-19 vaccines in Malawi as part of a telephone-based syndromic surveillance survey. We conducted telephone-based syndromic surveillance surveys with questions on COVID-19 vaccine receipt among adults (≥18 years old) upon verbal consent from July 2021 to April 2022. We used random digit dialing to select mobile phone numb…

  • Unlocking the potential

    Open AccessThulani Maphosa, Shalom Dunga et al.ARTICLEBMC Public Health2024

    This study provides insights into weight gain patterns in patients on DTG-based regimens compared with those on non-DTG regimens. Younger individuals (15-24 years) exhibited higher odds of weight gain, suggesting a need for increased surveillance in this age group. These findings contribute to the understanding DTG's potential effects on weight gain, aiding clinical decision making. Further research is required to comprehensively understand the u…

  • Safety of Janssen Ad26.COV.S and Astra Zeneca AZD1222 Covid-19 Vaccines among Mobile Phone Users in Malawi

    Open AccessLucky Makonokaya, Lester Kapanda et al.ARTICLEInternational Journal of…2023

    The safety profiles of the Ad26.COV2.S and AZD1222 COVID-19 vaccines have not been described in the general population in Malawi. We present self-reported adverse events (AE) following the receipt of these vaccines in Malawi as part of a national syndromic surveillance survey. We conducted phone-based syndromic surveillance surveys among adults (≥18 years) with verbal consent. We used secure tablets through random digit dialing to select mobile p…

  • Protocol for a Case-Control Study to Investigate the Association of Pellagra With Isoniazid Exposure During Tuberculosis Preventive Treatment Scale-Up in Malawi

    Open AccessScott A Nabity, Kelvin Mponda et al.ARTICLEFrontiers in Public Health2020

    Background: Pellagra is caused by niacin (vitamin B3) deficiency and manifested by a distinctive dermatitis. Isoniazid is critical for treating tuberculosis globally and is a component of most regimens to prevent tuberculosis. Isoniazid may contribute to pellagra by disrupting intracellular niacin synthesis. In 2017, Malawian clinicians recognized a high incidence of pellagra-like rashes after scale-up of isoniazid preventive treatment (IPT) to p…